References
- OlivieriNFBrittenhamGMIron-chelating therapy and the treatment of thalassemiaBlood1997897397619028304
- HartmannJBraulkeFSinzigUIron overload impairs proliferation of erythroid progenitors cells (BFU-E) from patients with myelodysplastic syndromesLeuk Res20133732733223259989
- MitnickJSBosniakMAMegibowAJCT in B-thalathassemia: iron deposition in the liver, spleen and lymph nodesAJR Am J Roentgenol1981136119111946786034
- TakatokuMUchiyamaTOkamotoSRetrospective nationwide survey of Japanese patients with transfusion-dependent MDS and aplastic anemia highlights the negative impact of iron overload on morbidity/mortalityEur J Hematol200778487494
- MalcovatiLImpact of transfusion dependency and secondary iron overload on the survival of patients with myelodysplastic syndromesLeuk Res200731Suppl 3S2S618037415
- HoffbrandAVTaherACappelliniMDHow I treat transfusional iron overloadBlood20121203657366922919029
- WellsRALeberBBucksteinRIron overload in myelodysplastic syndromes: a Canadian consensus guidelineLeuk Res2008321338135318405971
- ParchSJHanCWComplete hematopoietic recovery after continuous iron chelation therapy in a patient with severe aplastic anemia with secondary hemochromatosisJ Korean Med Sci20082332032318437019